Metadon Bioeel (Methadone Hydrochloride)

Methadone is a full agonist at the μ‑opioid receptor. By binding to this receptor, it activates the same pathways as other opioids, producing analgesia and reducing the neurochemical drive that causes withdrawal. Its long half‑life maintains steady drug levels, allowing once‑daily dosing in maintenance programs.

The dose of Metadon Bioeel is individualized. A qualified prescriber determines the appropriate starting amount and any subsequent adjustments based on the patient’s clinical condition, prior opioid exposure, and response to therapy. Dosing guidelines are not provided here and should be obtained from a healthcare professional.

Methadone is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out. It may be used if the potential benefit justifies the potential risk. Methadone does pass into breast milk, so breastfeeding mothers should discuss risks and benefits with their obstetric and neonatal care providers.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both methadone and buprenorphine are used for opioid dependence, but methadone is a full μ‑opioid receptor agonist, while buprenorphine is a partial agonist with a ceiling effect on respiratory depression. Methadone generally requires daily dosing and strict monitoring, whereas buprenorphine can be prescribed in take‑home formulations and may have a lower risk of overdose.

Store Metadon Bioeel at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Metadon Bioeel is taken orally. The tablet should be swallowed whole with a full glass of water. It is not intended for crushing, chewing, or dissolving, and should be taken exactly as prescribed by the treating clinician.

The most serious risks include respiratory depression, which can be fatal if not promptly managed, and cardiac arrhythmias due to QT‑interval prolongation. Overdose, severe hypotension, and rare allergic reactions such as anaphylaxis also represent critical safety concerns that require immediate medical attention.

Metadon Bioeel is contraindicated in patients with severe respiratory depression, acute asthma attacks, or known hypersensitivity to methadone or any excipients. It should also be avoided in individuals with uncontrolled cardiac arrhythmias or those taking medications that significantly increase methadone levels without appropriate monitoring.